Evidence map›Paper›PMID 31136732›Full record

ArticleAmerican journal of obstetrics and gynecology2019

Miscarriage among women in the United States Women's Interagency HIV Study, 1994-2017.

Kristin M Wall, Lisa B Haddad, C Christina Mehta, Elizabeth T Golub, Lisa Rahangdale, Jodie Dionne-Odom, Roksana Karim, Rodney L Wright, Howard Minkoff, Mardge Cohen and 4 more

Abstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Kristin M WallDepartment of Epidemiology, Rollins School of Public Heath, Emory University, Atlanta, GA. Electronic address: kmwall@emory.edu.
Lisa B HaddadDepartment of Gynecology and Obstetrics, School of Medicine, Emory University, Atlanta, GA.
C Christina MehtaDepartment of Biostatistics and Bioinformatics, Rollins School of Public Heath, Emory University, Atlanta, GA.
Elizabeth T GolubDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Heath, Baltimore, MD.
Lisa RahangdaleDepartment of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC.
Jodie Dionne-OdomDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL.
Roksana KarimDepartment of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Rodney L WrightDepartment of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, NY.
Howard MinkoffDepartment of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY.
Mardge CohenDepartment of Medicine, John H. Stroger Jr Hospital of Cook County, Chicago, IL; Rush University, Chicago, IL.
Seble G KassayeDepartment of Medicine, Division of Infectious Diseases and Travel Medicine, Georgetown University School of Medicine, Washington, DC.
Deborah CohanDepartment of Obstetrics and Gynecology, University of California, San Francisco, School of Medicine, San Francisco, CA.
Igho OfotokunDepartment of Medicine, Division of Infectious Diseases, Emory University, Atlanta, GA; Grady Healthcare System, Atlanta, GA.
Susan E CohnDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL.
Emory University · USAlbert Einstein College of Medicine · USGeorgetown University · USGrady Memorial Hospital · USJohn H. Stroger, Jr. Hospital of Cook County · USJohns Hopkins University · USMaimonides Medical Center · USNorthwestern University · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Aadia Rana · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
Women's Interagency HIV Study (WIHS) IV, Chicago ConsortiumU01AI034993 · NIAID · HEKTOEN INSTITUTE FOR MEDICAL RESEARCH · PI COHEN, MARDGE H, FRENCH, AUDREY · 1994 to 2018
$51.0M
WOMENS INTERAGENCY HIV STUDY (WIHS)U01HD032632 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MILAM, JOEL E · 1994 to 2012
$42.0M
WIHS DATA MANAGEMENT AND ANALYSIS CENTER(WDMAC)U01AI042590 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GANGE, STEPHEN J, GOLUB, ELIZABETH T · 1998 to 2018
$38.4M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR000454NHLBI NIH HHS U01 HL146192NHLBI NIH HHS U01 HL146194NHLBI NIH HHS U01 HL146203NHLBI NIH HHS U01 HL146205NHLBI NIH HHS U01 HL146242NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI034993NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI042590NIAID NIH HHS U01 AI103390NIAID NIH HHS U01 AI103397NIAID NIH HHS U01 AI103401NIAID NIH HHS U01 AI103408NIA NIH HHS R21 AG059505NICHD NIH HHS K23 HD078153NICHD NIH HHS K23 HD090993NICHD NIH HHS U01 HD032632NIMH NIH HHS K01 MH107320
6 · The paper itself

Abstract

backgroundRelatively little is known about the frequency and factors associated with miscarriage among women living with HIV.

objectiveThe objective of the study was to evaluate factors associated with miscarriage among women enrolled in the Women's Interagency HIV Study. STUDY

designWe conducted an analysis of longitudinal data collected from Oct. 1, 1994, to Sept. 30, 2017. Women who attended at least 2 Women's Interagency HIV Study visits and reported pregnancy during follow-up were included. Miscarriage was defined as spontaneous loss of pregnancy before 20 weeks of gestation based on self-report assessed at biannual visits. We modeled the association between demographic, behavioral, and clinical covariates and miscarriage (vs live birth) for women overall and stratified by HIV status using mixed-model logistic regression.

resultsSimilar proportions of women living with and without HIV experienced miscarriage (37% and 39%, respectively, P = .638). In adjusted analyses, smoking tobacco (adjusted odds ratio, 2.0), alcohol use (adjusted odds ratio, 4.0), and marijuana use (adjusted odds ratio, 2.0) were associated with miscarriage. Among women living with HIV, low HIV viral load (<4 log10 copies/mL) (adjusted odds ratio, 0.5) and protease inhibitor (adjusted odds ratio, 0.4) vs the nonuse of combination antiretroviral therapy use were protective against miscarriage.

conclusionWe did not find an increased odds of miscarriage among women living with HIV compared with uninfected women; however, poorly controlled HIV infection was associated with increased miscarriage risk. Higher miscarriage risk among women exposed to tobacco, alcohol, and marijuana highlight potentially modifiable behaviors. Given previous concern about antiretroviral therapy and adverse pregnancy outcomes, the novel protective association between protease inhibitors compared with non-combination antiretroviral therapy and miscarriage in this study is reassuring.

Indexed as

Abortion, SpontaneousAdultAlcohol DrinkingAntiretroviral Therapy, Highly ActiveFemaleHIV InfectionsHumansLogistic ModelsLongitudinal StudiesMarijuana UseOdds RatioPregnancyProtease InhibitorsProtective FactorsRisk FactorsTobacco SmokingProtease Inhibitorsantiretroviral treatmentHIVmarijuanamiscarriageWomen’s Interagency HIV Study

Identifiers

PMID31136732
PMCPMC6878114
OpenAlexW2944894903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.